People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tendyne Holdings, Inc. | — | Biotechnology | Series B | $67.5M | $992.2M | 2012 |
| Ocudyne, Inc. | — | Other Health Care | Series A | $10.1M | $21.9M | 2013 |
Jeffrey Franco at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey Franco on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joseph M. Smith | 2 | 3 |
| Martin J. Waters | 1 | 9 |
| Joseph Smith | 1 | 7 |
| Robert Atkinson | 1 | 3 |
| Kemal Schankereli | 1 | 2 |
| Edward W. Malouf | 1 | 2 |
| Greg Pearl | 1 | 2 |
| Jonathan Talamo | 1 | 2 |
| David W. McIntyre | 1 | 1 |
| Joseph W. Smith | 1 | 1 |
| Edward Mercaldo | 1 | 1 |
| Edward Malouf | 1 | 1 |
| Greg W. Pearl | 1 | 1 |
| Kemal W. Schankereli | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.